Spontaneous reduction of prolactinoma post cabergoline withdrawal

about

Spontaneous reduction of prolactinoma post cabergoline withdrawal

Item

http://www.wikidata.org/entity/Q42413987

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Spontaneous reduction of prolactinoma post cabergoline withdrawal

@en

Spontaneous reduction of prolactinoma post cabergoline withdrawal

@nl

type

Item

label

Spontaneous reduction of prolactinoma post cabergoline withdrawal

@en

Spontaneous reduction of prolactinoma post cabergoline withdrawal

@nl

prefLabel

Spontaneous reduction of prolactinoma post cabergoline withdrawal

@en

Spontaneous reduction of prolactinoma post cabergoline withdrawal

@nl

P1476

Spontaneous reduction of prolactinoma post cabergoline withdrawal

@en

P2093

Anil Taneja

http://www.w3.org/2001/XMLSchema#string

Bindu Kulshreshtha

http://www.w3.org/2001/XMLSchema#string

Deepak Kothari

http://www.w3.org/2001/XMLSchema#string

Sampath Kumar Venkatesh

http://www.w3.org/2001/XMLSchema#string

Smita Manchanda

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of Go-coupled dopamine D2 receptors inhibits ERK1/ERK2 in pituitary cells. A key step in the transcriptional suppression of the prolactin gene

Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis.

Clinical management of prolactinomas.

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.

Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs.

Treatment of pituitary tumors: dopamine agonists.

Pharmacologic resistance in prolactinoma patients.

Management of resistant prolactinomas.

Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas.

Inhibition of inositol phosphate production is a late, Ca2+-dependent effect of D2 dopaminergic receptor activation in rat lactotroph cells.

P304

833-835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4103/2230-8210.100656

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23087877

http://www.w3.org/2001/XMLSchema#string

P932

3475917

http://www.w3.org/2001/XMLSchema#string